We describe a new clinical laboratory instrument, the Abbott AXSYM , which provides random-and continuous-access testing for immunoassays, 20 onboard reagents, primary tube sampling, and a throughput of 80 to 120 tests per hour. The AxSYM incorporates three separate analytical technologies for processing immunoassays: microparticle enzyme immunoassay, fluorescence polarization immunoassay, and a novel technology known as ion-capture immunoassay. The system incorporates both common and technology-specific subsystems controlled by a real-time software scheduling processor. (Figures 1-3 
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Tests can be processed in one-or two-step sandwich or competitive formats, with variable pipethng steps, incubation periods, optical read formats, and wash sequences. Menu capabilities include tests for hepatitis, retrovirus, tumor markers, fertility markers, thyroid functions, and therapeutic drugs. The time to first result is -15-25 mm for most routine assays and 15 mm for stat assays (i.e., creatine kinase MB isoenzyme, human chorionic gonadotropin p subunit, and therapeutic drugs). AXSYM assay performance for 23 assays was comparable with that of the Abbott lMx#{174} and TDx#{174} analyzers; specimen correlation data had correlation coefficients ranging from 0.97 to 0.99 and slopes ranging from 0 It consists of a color monitor and touchscreen, keyboard, external 80-column printer, barcode wand, floppy disk drive for archiving data, and a dedi-cated RS232 port for bidirectional interface to a host computer.
Operating Procedure
The Abbott AxSYM is a completely automated system, requiring little operator intervention.
Test orders are downloaded from a host computer or entered directly through the Data Management Center. Samples are loaded onto the Sampling Center in any available position along with reagent packs and disposables. Sample containers accommodated by the system include 5-, 7-, and 10-mL primary tubes or 1-mL sample cups (provided for the system). Tests are processed in order of presentation to the pipettor. 
System Features

Disposables.
The system uses a common, multiwell disposable, the RV, for processing in the MEIA, FPIA, and ICIA assays. The RV (Figure 3, top) comprises a sample well, three reagent wells, an incubation well, a buffer well, a predilute well, and a plastic cuvette. RVs are manually loaded onto the RV carousel in strips of 10 for ease of handling.
MEIA and ICIA assays require an additional disposable, the matrix cell. The matrix cell (Figure 3, bottom) consists of a glass fiber matrix and blotter contained in by their proximity to the pipetting station. To guard against evaporation, the test constituents will not be pipetted until the scheduler ensures that all resources required for each test activity will be available at the times specified in the test's assay definition. When scheduling can be achieved, the test constituents are pipetted and transferred immediately into the Processing Center.
Stat samples are given priority in both the Sampling and Processing Centers of the system. Whenan operator notifies the system that a stat sample has been placed onboard the sample carousel, the system will complete the test it is currently pipetting, then move to the stat sample and pipet all tests requested on that sample. It will then return to its previous location and continue pipetting tests in the order of sample placement.
In the Processing Center, stat samples are processed according to a modified scheduling algorithm that allows them to be processed as quickly as possible.
Flexible protocol technology'. The instrument's mechanical components were developed in conjunction with the software scheduler to provide a system capable of processing tests in a variety of different protocol formats. This has allowed assays originally developed for the lMx and TDx analyzers to be adapted for the AxSYM with minimal change to their protocol structures. Test protocols are executed in competitive or sandwich formats, with either a one -or a two-step process. Examples of several types of assay protocols are illustrated in Table 1 . The thyroid-stimulating hormone (TSH) assay requires a separation step before the conjugate addition and a special wash for maximum sensitivity; it is processed in a two-step MEIA format with incubation periods optimized for the reaction kinetics. p-hCG is configured as a one-step MEIA for maximum performance, throughput, and turnaround time. The larger probe wash volumes required by this assay to reduce sample carryover are easily accommodated by the system. Theophylline, an FPIA, is processed as in the TDx, in a competitive homogeneous format.
Assay calibration.
Assay calibration for quantitative assays is accomplished by utilizing either a factorygenerated or an operator-performed six-point calibration. Calibrators used for AxSYM are identical to those used in the corresponding IMx and TDx products. Lotspecific master calibration curves generated in the factory from multiple instrument data are translated into a barcode that is entered into the system by the operator via a barcode wand at the time the new reagent lot is installed on the system. To adjust the factory curve to AxSYM assays. Assay sensitivity, defined as the minimum analytical detection limit, was calculated as the amount of analyte 2 SD above the mean of the zero standard. The data used in this calculation was obtained from nine runs of 10 samples each across three separate instruments.
Assay reproducibility was calculated from buffer heater block was also maintained well within the lated well with the lMx and TDx results. Assay sensi-34.5 #{176}C specification, with a mnimum range of ± 0.05 #{176}C. tivity and reproducibility are presented in RLU (CV = 0.08%). The average polarizaand onboard instrument conditions. Figure 5 shows the tion calculated for the FPIA standard was 49.6 mP results obtained for prostate-specific antigen.
Over the (CV = 1.3%).
18-day period of the study, the performance of the reCarryover performance.
p-hCG
and HBsAg were choagents stored at 31#{176}C for 8 h per day was comparable sen as model assays to assess carryover because these with that of the control reagents stored at 2-8 #{176}C. Simanalytes are characterized by large dynamic ranges and ilar results have been obtained for the other 22 AxSYM low sensitivity requirements. For -hCG, carryover of assays and support an onboard reagent stability of as <1 dU/L was obtained with a total wash volume per much as 112 h. assay of 10 mL. HBsAg carryover was reduced to -'0.1 ugfL by using a wash volume of 11 mL.
Assay performance.
The use of existing IMx and TDX reagents in conjunction with flexible processing has fa-
